A carregar...
Camrelizumab (SHR-1210) leading to reactive capillary hemangioma in the gingiva: A case report
BACKGROUND: Oncologic immunotherapy is attracting attention as an effective strategy for cancer treatment. Currently, there are two kinds of inhibitors: Anti-PD-1 antibodies and anti-PD-L1 antibodies. These inhibitors have shown significant implications in improving the outcomes of certain cancer ty...
Na minha lista:
| Publicado no: | World J Clin Cases |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7031842/ https://ncbi.nlm.nih.gov/pubmed/32110675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v8.i3.624 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|